North America Immune Repertoire Sequencing Market Size & Outlook
The immune repertoire sequencing market in North America is expected to reach a projected revenue of US$ 378.1 million by 2033. A compound annual growth rate of 11.9% is expected of North America immune repertoire sequencing market from 2025 to 2033.
- Biotechnology
- Sequencing technology
- Immune Repertoire Sequencing Market Outlook
- Sequencing technology
Revenue, 2025 (US$M)
$137.5
Estimate, 2026 (US$M)
$171.0
Forecast, 2033 (US$M)
$378.1
CAGR, 2026 - 2033
11.9%
Global Market
Related Markets
Ask Prism AI anything about the immune repertoire sequencing market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
North America immune repertoire sequencing market highlights
- The North America immune repertoire sequencing market generated a revenue of USD 137.5 million in 2024.
- The market is expected to grow at a CAGR of 11.9% from 2025 to 2033.
- In terms of segment, assay kits & reagents was the largest revenue generating product & service in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2033.
North America data book summary
| Market revenue in 2024 | USD 137.5 million |
| Market revenue in 2033 | USD 378.1 million |
| Growth rate | 11.9% (CAGR from 2025 to 2033) |
| Largest segment | Assay kits & reagents |
| Fastest growing segment | Services |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Assay Kits & Reagents, Services |
Other key industry trends
- In terms of revenue, North America region accounted for 41.9% of the global immune repertoire sequencing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 241.5 million by 2033.
No credit card required*
Publish Date: Jul 08, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immune Repertoire Sequencing Market Scope
Immune Repertoire Sequencing Market segmentation & scope
Others
Immune Repertoire Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | neb.com |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | www.creative-biolabs.com |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | www.genomics.cn/ |
| Illumina, Inc. | View profile | - | - | - |
| iRepertoire | View profile | 11-50 | Huntsville, Alabama, United States, North America | www.irepertoire.com/ |
| Celemics | View profile | 51-100 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.celemics.com |
North America Immune Repertoire Sequencing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immune Repertoire Sequencing Market Outlook will help companies and investors design strategic landscapes.
Assay Kits & Reagents was the largest segment with a revenue share of 55.05% in 2024.
Horizon Databook has segmented the North America immune repertoire sequencing market based on instruments, assay kits & reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
- North America Immune Repertoire Sequencing Market Product & Service Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Assay Kits & Reagents
- Services
- North America Immune Repertoire Sequencing Market Type Outlook (Revenue, USD Million , 2021-2033)
- Bulk immune repertoire sequencing
- Single cell immune repertoire sequencing
- North America Immune Repertoire Sequencing Market Application Outlook (Revenue, USD Million , 2021-2033)
- Oncology & Cancer Immunotherapy
- Autoimmune & Inflammatory Diseases
- Infectious Diseases & Vaccine Development
- Transplantation & Immune Tolerance
- Others
- North America Immune Repertoire Sequencing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Reasons to subscribe to Immune Repertoire Sequencing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Immune Repertoire Sequencing Market Outlook databook
- Our clientele includes a mix of Immune Repertoire Sequencing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Immune Repertoire Sequencing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Immune Repertoire Sequencing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Immune Repertoire Sequencing Market, 2021-2033 (US$M)
North America immune repertoire sequencing market statistics, by product & service, 2021-2033 (US$M)
